NasdaqCM - Nasdaq Real Time Price USD

The Beauty Health Company (SKIN)

Compare
1.5400 -0.1000 (-6.10%)
As of 12:03 PM EDT. Market Open.
Loading Chart for SKIN
DELL
  • Previous Close 1.6400
  • Open 1.6500
  • Bid 1.5300 x 100
  • Ask 1.5600 x 500
  • Day's Range 1.5200 - 1.6500
  • 52 Week Range 0.9100 - 6.7900
  • Volume 127,938
  • Avg. Volume 1,653,548
  • Market Cap (intraday) 190.991M
  • Beta (5Y Monthly) 0.96
  • PE Ratio (TTM) --
  • EPS (TTM) -0.8300
  • Earnings Date Nov 11, 2024 - Nov 15, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 3.08

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.

www.beautyhealth.com

881

Full Time Employees

December 31

Fiscal Year Ends

Recent News: SKIN

View More

Performance Overview: SKIN

Trailing total returns as of 9/18/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

SKIN
50.48%
S&P 500
17.82%

1-Year Return

SKIN
77.12%
S&P 500
26.28%

3-Year Return

SKIN
94.05%
S&P 500
26.77%

5-Year Return

SKIN
85.79%
S&P 500
54.58%

Compare To: SKIN

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: SKIN

View More

Valuation Measures

Annual
As of 9/17/2024
  • Market Cap

    203.39M

  • Enterprise Value

    421.46M

  • Trailing P/E

    --

  • Forward P/E

    27.32

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.61

  • Price/Book (mrq)

    2.94

  • Enterprise Value/Revenue

    1.15

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -22.85%

  • Return on Assets (ttm)

    -10.15%

  • Return on Equity (ttm)

    -72.46%

  • Revenue (ttm)

    366.23M

  • Net Income Avi to Common (ttm)

    -83.7M

  • Diluted EPS (ttm)

    -0.8300

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    349.54M

  • Total Debt/Equity (mrq)

    820.37%

  • Levered Free Cash Flow (ttm)

    29.01M

Research Analysis: SKIN

View More

Company Insights: SKIN

Research Reports: SKIN

View More

People Also Watch